Style | Citing Format |
---|---|
MLA | Fakhim H, et al.. "Features and Evaluation of Mucormycosis in Covid-19 Patients From Two Referral Hospitals in Iran." Journal of Medical Mycology, vol. 34, no. 2, 2024, pp. -. |
APA | Fakhim H, Irani S, Yassin Z, Badali H, Nasri E, Nasoori Y, Samimiardestani S, Mohebbi S, Mohammadi Ardehali M, Alizadeh Pahlavan P, Firouzifar M, Tajdini A, Ahadi S, Vaezi A (2024). Features and Evaluation of Mucormycosis in Covid-19 Patients From Two Referral Hospitals in Iran. Journal of Medical Mycology, 34(2), -. |
Chicago | Fakhim H, Irani S, Yassin Z, Badali H, Nasri E, Nasoori Y, Samimiardestani S, et al.. "Features and Evaluation of Mucormycosis in Covid-19 Patients From Two Referral Hospitals in Iran." Journal of Medical Mycology 34, no. 2 (2024): -. |
Harvard | Fakhim H et al. (2024) 'Features and Evaluation of Mucormycosis in Covid-19 Patients From Two Referral Hospitals in Iran', Journal of Medical Mycology, 34(2), pp. -. |
Vancouver | Fakhim H, Irani S, Yassin Z, Badali H, Nasri E, Nasoori Y, et al.. Features and Evaluation of Mucormycosis in Covid-19 Patients From Two Referral Hospitals in Iran. Journal of Medical Mycology. 2024;34(2):-. |
BibTex | @article{ author = {Fakhim H and Irani S and Yassin Z and Badali H and Nasri E and Nasoori Y and Samimiardestani S and Mohebbi S and Mohammadi Ardehali M and Alizadeh Pahlavan P and Firouzifar M and Tajdini A and Ahadi S and Vaezi A}, title = {Features and Evaluation of Mucormycosis in Covid-19 Patients From Two Referral Hospitals in Iran}, journal = {Journal of Medical Mycology}, volume = {34}, number = {2}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Fakhim H AU - Irani S AU - Yassin Z AU - Badali H AU - Nasri E AU - Nasoori Y AU - Samimiardestani S AU - Mohebbi S AU - Mohammadi Ardehali M AU - Alizadeh Pahlavan P AU - Firouzifar M AU - Tajdini A AU - Ahadi S AU - Vaezi A TI - Features and Evaluation of Mucormycosis in Covid-19 Patients From Two Referral Hospitals in Iran JO - Journal of Medical Mycology VL - 34 IS - 2 SP - EP - PY - 2024 ER - |